November at 08.30 CET. Management will be represented by CEO Ulf Ritsvall and CFO Eirik Underthun. A Q&A session will be held as a part of the webcast. Participants who have ...

20,000,000 new shares in the Company at a subscription price of NOK 0.50 per share (the "Subsequent Offering").

DNA and viral vectors, which can be deployed in multiple disease settings, including cell and gene -therapy and chronic diseases. The circVec platform has demonstrated enhanced and more durable ...

secured a 5-year maintenance contract of the systems. immediately, and delivery will take place in Q3-2025. (1) A sizeable contract is defined to be between NOK 20 million and NOK 50 million. (2) A ...

valued at approximately NOK 428 million excluding VAT. The buildings are located along the waterfront at Nøstet, very centrally in with squares, playgrounds, and a new public quay promenade designed ...

Thor Medical's CEO Jasper Kurth and CFO Brede Ellingsæter will present an ...

to announce that the C-45 infill well has successfully been put onstream by the Block G operator, Trident Energy, at an initial gross rate in excess of 5,000 bopd on a restricted choke, in line with ...

its 20% interest in the Bøyla field to Concedo AS for an after-tax consideration of USD 24 million. The transaction with Concedo AS is in line with Vår Energi's stated strategy to dispose of non-core ...

placement of new shares in DOF as announced by the Company on 2 - 3 July 2024 (the "Private Placement"), where MSSH was allocated 2,686,591 shares in DOF in a separate tranche ("Tranche 2"), subject ...

Haugland, all of Odfjell Technology AS. There will be a Q&A session after the presentation. Information on how to submit questions will be given at the beginning of the Q&A session. Please join the ...

upsized from the initial USD 40 million as the Company elected to use its option to settle the last USD 10 million, that were initially planned to be issued as Private Placement (together with the ...

The Company intends to use the net proceeds from the Reserved Offering to finance only its general corporate needs in connection with the slight delay the Company has experienced in the resumption of ...